24HourWire
News from all angles
南华早报
Center
US regulator investigates tumour risk in children given Novartis gene therapy
The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis’ gene therapy Zolgensma. The Swiss d…